Juan Antonio Virizuela

Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer

Noel W. Clarke, Andrew J. Armstrong, Antoine Thiery-Vuillemin et al. · NEJM Evidence · 2022 · 357 citations

Urology, Genitourinary Cancer, Medicine +8

Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial

Aleix Prat, Cristina Saura, Tomás Pascual et al. · The Lancet Oncology · 2019 · 191 citations

Breast Oncology, Medicine, Pharmacology +10

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 120 citations

Breast Oncology, Medicine, Cancer Management +7

SEOM clinical guidelines on nutrition in cancer patients (2018)

R. de las Peñas, Margarita Majem, Javier Pérez-Altozano et al. · Clinical & Translational Oncology · 2019 · 110 citations · Full text

Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study

Yolanda Escobar, Gerardo Cajaraville, Juan Antonio Virizuela et al. · Supportive Care in Cancer · 2015 · 79 citations · Full text